NGL FINE CHM share price has plunged 4% and is presently trading at Rs 2,351.9.
Meanwhile, the BSE HEALTHCARE index is at 41,949.3 (up 0.8%).
Among the top losers in the BSE HEALTHCARE index today are Aurobindo Pharma (down 2.7%) and Procter & Gamble Health (down 1.3%).
GSK Pharma (up 5.1%) and SUVEN PHARMACEUTICALS (up 4.4%) are among the top gainers today.
Over the last one year, NGL FINE CHM has moved up from Rs 1,986.7 to Rs 2,351.9, registering a gain of Rs 365.2 (up 18.4%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,021.8 to 41,949.3, registering a gain of 49.7% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 129.9%), GSK Pharma (up 117.0%) and Glenmark Pharma (up 115.7%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 80,685.2 (down 0.1%).
The top losers among the BSE Sensex today are Ultratech Cement (down 1.6%) and Tata Steel (down 1.1%). The most traded stocks in the BSE Sensex are Tata Steel and ITC.
In the meantime, NSE Nifty is at 24,704.2 . Divis Laboratories and Titan are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,216.1 to 80,685.2, registering a gain of 15,469.1 points (up 23.7%).
NGL FINE CHM net profit grew 8.4% YoY to Rs 92 million for the quarter ended June 2024, compared to a profit of Rs 85 million a year ago. Net sales rose 27.7% to Rs 908 million during the period as against Rs 710 million in April-June 2023.
For the year ended March 2024, NGL FINE CHM reported 101.6% increase in net profit to Rs 413 million compared to net profit of Rs 205 million during FY23. Revenue of the company grew 21.8% to Rs 3,387 million during FY24.
The current Price to earnings ratio of NGL FINE CHM, based on rolling 12 month earnings, stands at 34.5.
Equitymaster requests your view! Post a comment on "NGL FINE CHM Plunges 4%; BSE HEALTHCARE Index Up 0.8%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!